Caleres, Inc. $CAL Position Cut by Principal Financial Group Inc.

Principal Financial Group Inc. lowered its position in shares of Caleres, Inc. (NYSE:CAL) by 88.9% in the 3rd quarter, Holdings Channel reports. The fund owned 163,138 shares of the textile maker’s stock after selling 1,306,929 shares during the period. Principal Financial Group Inc.’s holdings in Caleres were worth $2,127,000 as of its most recent filing with the SEC.

Other hedge funds have also recently bought and sold shares of the company. Osaic Holdings Inc. grew its position in Caleres by 1,662.8% in the 2nd quarter. Osaic Holdings Inc. now owns 1,992 shares of the textile maker’s stock worth $25,000 after purchasing an additional 1,879 shares during the last quarter. CWM LLC boosted its position in shares of Caleres by 624.9% during the third quarter. CWM LLC now owns 3,639 shares of the textile maker’s stock worth $47,000 after buying an additional 3,137 shares during the period. New York State Common Retirement Fund grew its holdings in Caleres by 171.8% in the 3rd quarter. New York State Common Retirement Fund now owns 6,487 shares of the textile maker’s stock worth $85,000 after buying an additional 4,100 shares in the last quarter. Arizona State Retirement System acquired a new stake in Caleres in the 3rd quarter valued at approximately $130,000. Finally, Nomura Holdings Inc. bought a new stake in Caleres during the 2nd quarter valued at $136,000. 98.44% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

CAL has been the subject of several recent analyst reports. Weiss Ratings reissued a “sell (d+)” rating on shares of Caleres in a research note on Wednesday, January 21st. Zacks Research cut shares of Caleres from a “hold” rating to a “strong sell” rating in a research note on Wednesday, January 28th. One analyst has rated the stock with a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Sell” and an average target price of $14.00.

Caleres Trading Up 3.2%

NYSE:CAL opened at $12.19 on Wednesday. Caleres, Inc. has a twelve month low of $9.54 and a twelve month high of $18.27. The company has a 50-day moving average of $12.97 and a 200-day moving average of $13.13. The firm has a market cap of $413.34 million, a price-to-earnings ratio of 19.35 and a beta of 0.64.

Caleres (NYSE:CAL) last released its earnings results on Tuesday, December 9th. The textile maker reported $0.67 EPS for the quarter, missing the consensus estimate of $0.75 by ($0.08). The business had revenue of $790.05 million for the quarter, compared to analyst estimates of $768.59 million. Caleres had a net margin of 0.78% and a return on equity of 8.62%. The firm’s revenue for the quarter was up 6.6% on a year-over-year basis. During the same period in the prior year, the company earned $1.23 earnings per share. Caleres has set its FY 2025 guidance at 0.550-0.60 EPS. On average, research analysts forecast that Caleres, Inc. will post 3.23 earnings per share for the current year.

Caleres Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 9th. Stockholders of record on Friday, December 26th were paid a dividend of $0.07 per share. The ex-dividend date of this dividend was Friday, December 26th. This represents a $0.28 annualized dividend and a dividend yield of 2.3%. Caleres’s dividend payout ratio (DPR) is currently 44.44%.

Caleres Company Profile

Caleres, Inc, formerly known as Brown Shoe Company, is a leading footwear company engaged in the design, sourcing, marketing and selling of a broad portfolio of branded and private-label shoes. The company’s operations span a range of market segments from value-priced to premium and luxury. Caleres operates through two primary segments: a retail segment anchored by the Famous Footwear banner, which includes more than 1,100 stores across North America, and a brand portfolio segment comprising owned and licensed brands such as Allen Edmonds, Naturalizer, Sam Edelman, Dr.